Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Per Kogner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Neoplasm Staging

Genes & Molecular Sequences

Physiology

Neoplastic Gene Expression Regulation

Procedures

Xenograft Model Antitumor Assays

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hanaka Hiromi; Pawelzik Sven-Christian; Johnsen John Inge; Rakonjac Marija; Terawaki Kan; Rasmuson Agnes; Sveinbjörnsson Baldur; Schumacher Martin C; Hamberg Mats; Samuelsson Bengt; Jakobsson Per-Johan; Kogner Per; Rådmark Olof
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Sköldenberg Erik G; Larsson Anders; Jakobson Ake; Hedborg Fredrik; Kogner Per; Christofferson Rolf H; Azarbayjani Faranak
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
Johnsen John Inge; Kogner Per; Albihn Ami; Henriksson Marie Arsenian
Embryonal neural tumours and cell death.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Per Kogner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hanaka Hiromi; Pawelzik Sven-Christian; Johnsen John Inge; Rakonjac Marija; Terawaki Kan; Rasmuson Agnes; Sveinbjörnsson Baldur; Schumacher Martin C; Hamberg Mats; Samuelsson Bengt; Jakobsson Per-Johan; Kogner Per; Rådmark Olof
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(44):18757-62.
2009: Sköldenberg Erik G; Larsson Anders; Jakobson Ake; Hedborg Fredrik; Kogner Per; Christofferson Rolf H; Azarbayjani Faranak
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
Anticancer research 2009;29(8):3311-9.
2009: Johnsen John Inge; Kogner Per; Albihn Ami; Henriksson Marie Arsenian
Embryonal neural tumours and cell death.
Apoptosis : an international journal on programmed cell death 2009;14(4):424-38.
2009: Wilzén Annica; Nilsson Staffan; Sjöberg Rose-Marie; Kogner Per; Martinsson Tommy; Abel Frida
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.
International journal of oncology 2009;34(3):697-705.
2009: Thorell Kaisa; Bergman Annika; Carén Helena; Nilsson Staffan; Kogner Per; Martinsson Tommy; Abel Frida
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes.
BMC medical genomics 2009;2():53.
2008: Carén Helena; Abel Frida; Kogner Per; Martinsson Tommy
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.
The Biochemical journal 2008;416(2):153-9.
2008: Hovén Emma; Anclair Malin; Samuelsson Ulf; Kogner Per; Boman Krister K
The influence of pediatric cancer diagnosis and illness complication factors on parental distress.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2008;30(11):807-14.
2008: Baryawno Ninib; Sveinbjörnsson Baldur; Eksborg Staffan; Orrego Abiel; Segerström Lova; Oqvist Carl Otto; Holm Stefan; Gustavsson Bengt; Kågedal Bertil; Kogner Per; Johnsen John Inge
Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.
Neuro-oncology 2008;10(5):661-74.
2008: Sveinbjörnsson Baldur; Rasmuson Agnes; Baryawno Ninib; Wan Min; Pettersen Ingvild; Ponthan Frida; Orrego Abiel; Haeggström Jesper Z; Johnsen John I; Kogner Per
Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(10):3525-36.
2008: Geli Janos; Kogner Per; Lanner Fredrik; Natalishvili Natalia; Juhlin Christofer; Kiss Nimrod; Clark Geoffrey J; Ekström Tomas J; Farnebo Filip; Larsson Catharina
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
International journal of cancer. Journal international du cancer 2008;123(2):389-94.
2008: Johnsen J I; Segerström L; Orrego A; Elfman L; Henriksson M; Kågedal B; Eksborg S; Sveinbjörnsson B; Kogner P
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo.
Oncogene 2008;27(20):2910-22.
2008: De Geer Anna; Carlson Lena-Maria; Kogner Per; Levitskaya Jelena
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma.
Cancer immunology, immunotherapy : CII 2008;57(5):731-43.
2008: Krona Cecilia; Carén Helena; Sjöberg Rose-Marie; Sandstedt Bengt; Laureys Genevieve; Kogner Per; Martinsson Tommy
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
International journal of oncology 2008;32(3):575-83.
2008: Carlson Lena-Maria; Påhlman Sven; De Geer Anna; Kogner Per; Levitskaya Jelena
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells.
Cell research 2008;18(3):398-411.
2008: Carén Helena; Erichsen Jennie; Olsson Linda; Enerbäck Charlotta; Sjöberg Rose-Marie; Abrahamsson Jonas; Kogner Per; Martinsson Tommy
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
BMC genomics 2008;9():353.
2007: Carén H; Fransson S; Ejeskär K; Kogner P; Martinsson T
Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours.
British journal of cancer 2007;97(10):1416-24.
2007: Wickström Malin; Johnsen John Inge; Ponthan Frida; Segerström Lova; Sveinbjörnsson Baldur; Lindskog Magnus; Lövborg Henrik; Viktorsson Kristina; Lewensohn Rolf; Kogner Per; Larsson Rolf; Gullbo Joachim
The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
Molecular cancer therapeutics 2007;6(9):2409-17.
2007: Geli Janos; Kiss Nimrod; Lanner Fredrik; Foukakis Theodoros; Natalishvili Natalia; Larsson Olle; Kogner Per; Höög Anders; Clark Geoffrey J; Ekström Tomas J; Bäckdahl Martin; Farnebo Filip; Larsson Catharina
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
Endocrine-related cancer 2007;14(1):125-34.
2007: Ponthan Frida; Wickström Malin; Gleissman Helena; Fuskevåg Ole M; Segerström Lova; Sveinbjörnsson Baldur; Redfern Christopher P F; Eksborg Staffan; Kogner Per; Johnsen John I
Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):1036-44.
2007: Jacobsson Hans; Hellström Per M; Kogner Per; Larsson Stig A
Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children: persisting regional functional differences after birth?
Clinical nuclear medicine 2007;32(1):24-8.
2006: Eliassen Liv Tone; Berge Gerd; Leknessund Arild; Wikman Mari; Lindin Inger; Løkke Cecilie; Ponthan Frida; Johnsen John Inge; Sveinbjørnsson Baldur; Kogner Per; Flaegstad Trond; Rekdal Øystein
The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo.
International journal of cancer. Journal international du cancer 2006;119(3):493-500.
2006: Lindskog Magnus; Gleissman Helena; Ponthan Frida; Castro Juan; Kogner Per; Johnsen John Inge
Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.
International journal of cancer. Journal international du cancer 2006;118(10):2584-93.
2006: Santic Radmila; Fenninger Katrin; Graf Kerstin; Schneider Rainer; Hauser-Kronberger Cornelia; Schilling Freimut H; Kogner Per; Ratschek Manfred; Jones Neil; Sperl Wolfgang; Kofler Barbara
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene.
Journal of molecular neuroscience : MN 2006;29(2):145-52.
2005: Johnsen John I; Lindskog Magnus; Ponthan Frida; Pettersen Ingvild; Elfman Lotta; Orrego Abiel; Sveinbjörnsson Baldur; Kogner Per
NSAIDs in neuroblastoma therapy.
Cancer letters 2005;228(1-2):195-201.
2005: Lindskog Magnus; Spenger Christian; Klason Tomas; Jarvet Jüri; Gräslund Astrid; Johnsen John Inge; Ponthan Frida; Douglas Lena; Nordell Bo; Kogner Per
Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.
Cancer letters 2005;228(1-2):247-55.
2005: Berger Alexandra; Santic Radmila; Hauser-Kronberger Cornelia; Schilling Freimut H; Kogner Per; Ratschek Manfred; Gamper Agnes; Jones Neil; Sperl Wolfgang; Kofler Barbara
Galanin and galanin receptors in human cancers.
Neuropeptides 2005;39(3):353-9.
2005: Abel Frida; Sjöberg Rose-Marie; Nilsson Staffan; Kogner Per; Martinsson Tommy
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology.
European journal of cancer (Oxford, England : 1990) 2005;41(4):635-46.
2004: Johnsen John I; Pettersen Ingvild; Ponthan Frida; Sveinbjørnsson Baldur; Flaegstad Trond; Kogner Per
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
International journal of oncology 2004;25(6):1849-57.
2004: Astuti D; Morris M; Krona C; Abel F; Gentle D; Martinsson T; Kogner P; Neumann H P H; Voutilainen R; Eng C; Rustin P; Latif F; Maher E R
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
British journal of cancer 2004;91(10):1835-41.
2004: Johnsen John I; Lindskog Magnus; Ponthan Frida; Pettersen Ingvild; Elfman Lotta; Orrego Abiel; Sveinbjörnsson Baldur; Kogner Per
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
Cancer research 2004;64(20):7210-5.
2004: Lindskog Magnus; Spenger Christian; Jarvet Jüri; Gräslund Astrid; Kogner Per
Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Journal of the National Cancer Institute 2004;96(19):1457-66.
2004: Boman Krister K; Viksten Jonas; Kogner Per; Samuelsson Ulf
Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective.
The Journal of pediatrics 2004;145(3):373-9.
2004: Kågedal Bertil; Kullman Anita; Lenner Liselotte; Träger Catarina; Kogner Per; Farnebäck Malin
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2004;17(4):346-51.
2004: Astuti D; Da Silva N F; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher E R
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma.
British journal of cancer 2004;90(2):515-21.
2003: Vertuani Simona; De Geer Anna; Levitsky Victor; Kogner Per; Kiessling Rolf; Levitskaya Jelena
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
Cancer research 2003;63(22):8006-13.
2003: Ponthan Frida; Lindskog Magnus; Karnehed Nina; Castro Juan; Kogner Per
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Oncology reports 2003;10(5):1587-92.
2003: Krona Cecilia; Ejeskär Katarina; Abel Frida; Kogner Per; Bjelke Jill; Björk Elin; Sjöberg Rose-Marie; Martinsson Tommy
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Oncogene 2003;22(15):2343-51.
2003: Ponthan Frida; Johnsen John Inge; Klevenvall Lena; Castro Juan; Kogner Per
The synthetic retinoid RO 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo.
International journal of cancer. Journal international du cancer 2003;104(4):418-24.
2003: Svechnikova Irina; Gray Steven G; Kundrotiene Jurgita; Ponthan Frida; Kogner Per; Ekström Tomas J
Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
International journal of oncology 2003;22(3):579-88.
2003: Lindskog M; Kogner P; Ponthan F; Schweinhardt P; Sandstedt B; Heiden T; Helms G; Spenger C
Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (1H MRS).
British journal of cancer 2003;88(3):478-85.
2003: Träger Catarina; Kogner Per; Lindskog Magnus; Ponthan Frida; Kullman Anita; Kågedal Bertil
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.
Clinical chemistry 2003;49(1):104-12.
2002: Berger Alexandra; Tuechler Camilla; Almer Dietmar; Kogner Per; Ratschek Manfred; Kerbl Reinhold; Iismaa Tiina P; Jones Neil; Sperl Wolfgang; Kofler Barbara
Elevated expression of galanin receptors in childhood neuroblastic tumors.
Neuroendocrinology 2002;75(2):130-8.
2002: Fröstad B; Tani E; Brosjö O; Skoog L; Kogner P
Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor.
Medical and pediatric oncology 2002;38(1):33-40.
2001: Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
British journal of cancer 2001;85(12):2004-9.
2001: Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann H P; Voutilainen R; Dahia P; Eng C; Maher E R; Latif F
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Oncogene 2001;20(51):7573-7.
2001: Dahllöf G; Borgström P; Lundell G; Jacobsson H; Kogner P
Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2001;92(4):420-3.
2001: Ejeskär K; Sjöberg R M; Abel F; Kogner P; Ambros P F; Martinsson T
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Medical and pediatric oncology 2001;36(1):61-6.
2001: Schilling F H; Ambros P F; Bihl H; Martinsson T; Ambros I M; Borgström P; Jacobsson H; Falkmer U G; Treuner J; Kogner P
Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas.
Medical and pediatric oncology 2001;36(1):56-60.
2001: Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern C P; Kogner P
The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
Medical and pediatric oncology 2001;36(1):127-31.
2000: Schilling F H; Bihl H; Jacobsson H; Ambros P F; Martinsson T; Borgström P; Schwarz K; Ambros I M; Treuner J; Kogner P
Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information.
Medical and pediatric oncology 2000;35(6):688-91.
2000: Jørgensen G E; Johnsen J I; Ponthan F; Kogner P; Flaegstad T; Traavik T
Human polyomavirus BK (BKV) and neuroblastoma: mechanisms of oncogenic action and possible strategy for novel treatment.
Medical and pediatric oncology 2000;35(6):593-6.
2000: Gray S G; Hartmann W; Eriksson T; Ekstrom C; Holm S; Kytola S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekstrom T J
Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.
International journal of molecular medicine 2000;6(2):161-9.
2000: Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
British journal of cancer 2000;83(2):171-6.
2000: Gray S G; Eriksson T; Ekström C; Holm S; von Schweinitz D; Kogner P; Sandstedt B; Pietsch T; Ekström T J
Altered expression of members of the IGF-axis in hepatoblastomas.
British journal of cancer 2000;82(9):1561-7.
2000: Ejeskär K; Abel F; Sjöberg R; Bäckström J; Kogner P; Martinsson T
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.
Cytogenetics and cell genetics 2000;89(1-2):62-6.
1999: Abel F; Ejeskär K; Kogner P; Martinsson T
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.
British journal of cancer 1999;81(8):1402-9.
1999: Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
Biodistribution of liposomal 131I-VIP in rat using gamma camera.
Nuclear medicine and biology 1999;26(8):931-6.
1999: Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson S A; Jacobsson H; Kogner P
The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo.
Pediatric research 1999;46(3):328-32.
1999: Ejeskär K; Sjöberg R M; Kogner P; Martinsson T
Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.
International journal of molecular medicine 1999;3(6):585-9.
1999: Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
Cancer 1999;87(2):60-8.
1999: Flaegstad T; Andresen P A; Johnsen J I; Asomani S K; Jørgensen G E; Vignarajan S; Kjuul A; Kogner P; Traavik T
A possible contributory role of BK virus infection in neuroblastoma development.
Cancer research 1999;59(5):1160-3.
1999: Fredriksson A; Johnström P; Thorell J O; von Heijne G; Hassan M; Eksborg S; Kogner P; Borgström P; Ingvar M; Stone-Elander S
In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.
Life sciences 1999;65(2):165-74.
1998: Eder U; Fischer-Colbrie R; Kogner P; Leitner B; Bjellerup P; Winkler H
Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.
Neuroscience letters 1998;253(1):17-20.
1998: Ejeskär K; Aburatani H; Abrahamsson J; Kogner P; Martinsson T
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
British journal of cancer 1998;77(11):1787-91.
1998: Fröstad B; Tani E; Kogner P; Maeda S; Björk O; Skoog L
The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours.
European journal of cancer (Oxford, England : 1990) 1998;34(4):529-36.
1998: Li X; Kogner P; Sandstedt B; Haas O A; Ekström T J
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma.
International journal of cancer. Journal international du cancer 1998;75(2):176-80.
1997: Svensson T; Rydén M; Schilling F H; Dominici C; Sehgal R; Ibáñez C F; Kogner P
Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2058-63.
1997: Kogner P; Borgström P; Bjellerup P; Schilling F H; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
Somatostatin in neuroblastoma and ganglioneuroma.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2084-9.
1997: Martinsson T; Sjöberg R M; Hallstensson K; Nordling M; Hedborg F; Kogner P
Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
European journal of cancer (Oxford, England : 1990) 1997;33(12):1997-2001.
1997: Martinsson T; Sjöberg R M; Hedborg F; Kogner P
Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma.
Cancer genetics and cytogenetics 1997;95(2):183-9.
1996: Rydén M; Sehgal R; Dominici C; Schilling F H; Ibáñez C F; Kogner P
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
British journal of cancer 1996;74(5):773-9.
1995: Martinsson T; Sjöberg R M; Hedborg F; Kogner P
Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Cancer research 1995;55(23):5681-6.
1995: Kogner P
Neuropeptides in neuroblastomas and ganglioneuromas.
Progress in brain research 1995;104():325-38.
1995: Kogner P; Bjellerup P; Svensson T; Theodorsson E
Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):557-60.
1995: Bjellerup P; Theodorsson E; Kogner P
Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery.
European journal of cancer (Oxford, England : 1990) 1995;31A(4):481-5.
1994: Kogner P; Björk O; Theodorsson E
Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval.
Acta paediatrica (Oslo, Norway : 1992) 1994;83(4):423-7.
1994: Kogner P; Barbany G; Persson H; Söderhäll S; Ahström L; Björk O
Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma.
Progress in clinical and biological research 1994;385():147-53.
1994: Kogner P; Barbany G; Björk O; Castello M A; Donfrancesco A; Falkmer U G; Hedborg F; Kouvidou H; Persson H; Raschella G
Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Progress in clinical and biological research 1994;385():137-45.
1993: Kogner P; Barbany G; Dominici C; Castello M A; Raschellá G; Persson H
Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Cancer research 1993;53(9):2044-50.
1993: Kogner P; Björk O; Theodorsson E
Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
Medical and pediatric oncology 1993;21(5):317-22.
1992: Kogner P; Ericsson A; Barbany G; Persson H; Theodorsson E; Björk O
Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia.
Blood 1992;80(5):1324-9.
1992: Hedborg F; Lindgren P G; Johansson I; Kogner P; Samuelsson B O; Bekassy A N; Olsen L; Kreuger A; Påhlman S
N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis.
Medical and pediatric oncology 1992;20(4):292-300.
1991: Kogner P; Theodorsson E; Björk O
Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
Progress in clinical and biological research 1991;366():367-73.
1991: Kogner P; Björk O; Hedborg F; Nordenskjöld A; Nordenskjöld M; Söderhäll S; Theodorsson E
Characterization of neuropeptide Y in pediatric neural crest tumors: relation to tumor malignancy and genetic findings.
Progress in clinical and biological research 1991;366():351-7.
1990: Kogner P; Björk O; Theodorsson E
Neuropeptide Y as a marker in pediatric neuroblastoma.
Pediatric pathology / affiliated with the International Paediatric Pathology Association 1990;10(1-2):207-16.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Per Kogner

Research Profile (preview)

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Per Kogner (preview)

All Publications